Regulatory barriers to clinical trial enrollment of adolescent and young adult oncology patients.
Where this comes from
- Record sourced from PubMed, PMID 24918210.
- Also identified by DOI 10.1542/peds.2014-0122H.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Adolescent and young adult (AYA) patients with cancer may face unique challenges if they and their families wish to participate in clinical oncology trials. Regulatory guidelines and funding requirements put in place to protect patients may actually raise barriers to enrollment in clinical trials. Hospital age guidelines may need to be readdressed to better suit the needs of AYA patients. Finally, the creation of the National Clinical Trials Network will provide new opportunities for pediatric and medical oncologists to collaborate in the care of AYA patients.
Medical subject headings
- Clinical Trials as Topic
- Medical Oncology
- Neoplasms
- Practice Guidelines as Topic